Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Philip Falcone and Harbinger Capital’s Wireless Adventure

Philip Falcone’s Harbinger Capital Partners dove into an illiquid and risky wireless adventure- one which proved to be a big concern for his investors. The adventure brought some legal troubles for both Harbinger and Philip Falcone.


Philip Falcone is famous for betting against subprime mortgages, which made Harbinger $11 Billion in 2007. Harbinger Capital Partners Fund returned 116% that year. Harbinger was doing fine until mid 2008, but Falcone’s flagship fund lost half its value during the rest of 2008. Phil Falcone’s Harbinger returned 42% in 2009, which was much better than most funds. However, 2010 was very bad for him. He lost about 12% in 2010.

Harbinger’s assets under management reached $26 Billion at its peak, but recently went back down to around $7 Billion. Investors have been doubting Philip Falcone’s ambitious wireless investments. These investments both led to poor performance and redemptions. Falcone’s illiquid investments is also one of the reasons why he couldn’t meet redemption requests in a timely manner.

Some investors see Falcone’s LightSquared investment as a giant gamble. He’s building a wholesale wireless network that will compete with AT&T (T) and Verizon (VZ), and he’s been launching satellites to achieve his dream. LightSquared already raised $2 Billion but probably needs another $6 Billion to complete its network.

According to Reuters, Harbinger is reducing headcount to cut expenses. This week 39-year-old Lawrence Clark left Harbinger to start his own fund. Kenneth Turano, 29 year old trader, left Harbinger probably to join Clark in the new fund. Two other investment analysts Clark Baker, 49, and Eli Benson, 36, were laid off.

Philip Falcone’s Harbinger has other investments as well. Here are some of his holdings at the end of September:

1. iPath S&P 500 VIX Short-Term Futures ETN (VXX): Harbinger had more than $60 Million of VXX in its portfolio. VXX was one of the best stocks to short after the increase in volatility at the end of May. VXX declined more than 50% since September 30th, adding to Phil Falcone’s woes.

2. Cliffs Natural Resources Inc (CLF): Cliffs Natural Resources returned more than 39%. Insiders at Cliffs Natural were selling during the past quarter as the stock kept climbing.

3. Corn Products Intl. (CPO): The stock increased nearly 28% since September. Three insiders at Corn Products Intl were selling below $45, and there was another insider, James P. Zallie, who bought more than 3,000 shares at $46.87.

4. Crosstex Energy Inc (XTXI): Crosstex Energy returned 14.4% since September, beating the S&P 500 by 1 percentage point. Susan J Mcaden, VP Accounting, sold more than 10,000 shares in November.

5. Exco Resources (XCO): Harbinger had nearly $99 Million invested in XCO and the stock returned 31.5% since September.

6. New York Times (NYT): This is another failed investment of Harbinger. They still had $95 Million of New York Times stock at the end of September. The stock gained 32% since then.

7. SPDR Gold Shares (GLD): Harbinger is one of the hedge funds that invests in gold. Daniel Loeb’s Third Point and Brevan Howard are also investors in GLD.  There are several other hedge funds that invest in gold through gold miners or hold physical gold. (See Paulson & Co Holdings, Curtis Schenker’s Scoggin Capital, David Einhorn’s Greenlight Capital, and Mohnish Pabrai’s holdings)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!